CME Group Inc. $CME Stock Purchased by Kintegral Advisory LLC

Kintegral Advisory LLC grew its holdings in shares of CME Group Inc. (NASDAQ:CME) by 608.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 52,901 shares of the financial services provider’s stock after buying an additional 45,431 shares during the quarter. CME Group makes up 1.0% of Kintegral Advisory LLC’s portfolio, making the stock its 23rd largest position. Kintegral Advisory LLC’s holdings in CME Group were worth $13,859,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. NBT Bank N A NY grew its holdings in shares of CME Group by 2.3% in the 1st quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock valued at $492,000 after acquiring an additional 38 shares in the last quarter. Resonant Capital Advisors LLC raised its holdings in CME Group by 3.8% during the first quarter. Resonant Capital Advisors LLC now owns 1,073 shares of the financial services provider’s stock worth $317,000 after acquiring an additional 39 shares in the last quarter. Grove Bank & Trust raised its holdings in CME Group by 0.8% during the third quarter. Grove Bank & Trust now owns 5,038 shares of the financial services provider’s stock worth $1,320,000 after acquiring an additional 39 shares in the last quarter. Root Financial Partners LLC boosted its position in CME Group by 13.2% during the first quarter. Root Financial Partners LLC now owns 394 shares of the financial services provider’s stock valued at $116,000 after purchasing an additional 46 shares during the last quarter. Finally, AlphaCentric Advisors LLC boosted its position in CME Group by 6.1% during the first quarter. AlphaCentric Advisors LLC now owns 821 shares of the financial services provider’s stock valued at $242,000 after purchasing an additional 47 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at CME Group

In related news, CEO Terrence A. Duffy sold 15,000 shares of the stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $274.44, for a total value of $4,116,600.00. Following the sale, the chief executive officer owned 40,630 shares in the company, valued at approximately $11,150,497.20. This represents a 26.96% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Elizabeth A. Cook sold 500 shares of the firm’s stock in a transaction on Monday, September 14th. The shares were sold at an average price of $280.11, for a total value of $140,055.00. Following the sale, the director directly owned 17,916 shares of the company’s stock, valued at $5,018,450.76. This represents a 2.72% decrease in their position. The SEC filing for this sale provides additional information. 0.30% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts have weighed in on the company. Bank of America raised their price target on CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a research note on Thursday, July 23rd. Deutsche Bank Aktiengesellschaft cut CME Group from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $286.00 to $270.00 in a research note on Wednesday, August 19th. Morgan Stanley increased their price objective on CME Group from $330.00 to $337.00 and gave the company an “overweight” rating in a report on Friday, October 9th. Weiss Ratings raised shares of CME Group from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Finally, Raymond James Financial reissued an “outperform” rating and issued a $320.00 target price on shares of CME Group in a research note on Thursday, July 2nd. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $292.94.

CME Group Stock Performance

Shares of CME stock traded up $4.41 on Friday, reaching $293.87. The stock had a trading volume of 2,180,230 shares, compared to its average volume of 1,887,081. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm’s 50-day moving average is $274.12 and its two-hundred day moving average is $270.77. The firm has a market capitalization of $105.67 billion, a price-to-earnings ratio of 24.93, a P/E/G ratio of 3.79 and a beta of 0.24. CME Group Inc. has a 12 month low of $218.31 and a 12 month high of $329.16.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. The business had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%. CME Group’s quarterly revenue was up .8% on a year-over-year basis. During the same quarter last year, the company posted $2.96 earnings per share. On average, research analysts expect that CME Group Inc. will post 12.29 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th were given a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend was Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 44.11%.

CME Group Company Profile

CME Group Inc operates global derivatives marketplaces that enable customers to manage risk and trade futures and options contracts. Its exchanges offer products linked to interest rates, equity indexes, foreign currencies, agricultural commodities, energy, metals and other asset classes.

The company also provides central counterparty clearing, settlement and related risk-management services for transactions conducted on its markets. In addition, CME Group offers market data, benchmark products and technology services that support trading, analysis and connectivity for financial institutions, businesses, professional traders and other market participants.

CME Group’s history includes the Chicago Board of Trade, founded in 1848, and the Chicago Mercantile Exchange, established in 1898.